Pharmaceutical Intermediate Raw Material Ceritinib Powder Ceritinib

Name: Pharmaceutical Intermediate Raw Material Ceritinib Powder Ceritinib
Brand: Shaanxi Haibo Biological Technology Co., Ltd
SKU: 2040221642

Shaanxi, ChinaShaanxi Haibo Biological Technology Co., Ltd

US$60.00

1-49 g

US$50.00

50-499 g

US$40.00

500+ g

Sample price:US$60.00/g.Request sample

Product profile

Customization

Available

Powder

Yes

Customized

Model NO.

HB-Ceritinib Powder

Certification

GMP, HSE, ISO 9001, USP, BP

Suitable for

Elderly, Children, Adult

Purity

>99%

Appearance

White Powder

Assay

99%

Grade

Food Grade

Place of Origin

Shaanxi, China

Package

1kg/Foil Bag, 25kg/Drum

Storage

Cool Dry Place

Transport Package

1kg/Foil Bag, 25kg/Drum

Specification

99%

Trademark

HAIBO

Origin

China

HS Code

0000

Production Capacity

99999kg/Weeks

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryLow MOQ

Shaanxi Haibo Biological Technology Co., Ltd

Shaanxi, China

CertifiedBusiness Type: Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs CertifiedExport Year: 3 Years CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤6.44h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryShaanxi Haibo Biological Technology Co., Ltd is a trading company based in Xi'an, Shaanxi, China. Established in 2020, the company specializes in beverage production, cosmetics, and various import-export services. It has limited innovation and production capabilities, as evidenced by no new product launches or ODM services offered in the past year, and only one R&D engineer. Financial capacity appears stable, with cash flow and financial data available up to 2023. The company lacks after-sales service infrastructure, such as overseas warehouses or showrooms, and does not participate in offline trade shows.

Supplier typeThe supplier is categorized as a Trading Company, operating under the name Shaanxi Haibo Biological Technology Co., Ltd.

After-Sales capabilityThe supplier lacks overseas warehouses and showrooms and does not have the capability to provide services through overseas agents or participate in trade shows.

Financial creditFinancial capacity and cash flow data are available up to 2023, indicating a level of financial monitoring and reporting.

R&D capabilityThe supplier has limited innovation capability, with no new products launched and no ODM services in the past year.

Production capacityThe production capability is constrained with only one R&D engineer and no new product launches in the past year.

Customization capabilityThe supplier offers customization from designs and samples but does not provide ODM services.